IL-32–treated tumors displayed an approximately 3-fold increase in absolute numbers of CD8+ T cells within the tumor (Figure 4, J and K) as well as significantly increased frequencies of IFN-γ+ (Figure 4L) and Nur77-GFP+ CD8+ T cells (Figure 4M). This evidence concerns the gene IL32 and neoplasm.